EUVIMEDEUVIMED entdecken
Crossref

Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy

Lixiao Zhang, Yuting Xin, Qidong You iD, Lei Wang iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.202500794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Lixiao Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 21000…. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Antineoplastic Agents, Chaperonins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell division cycle 37 (CDC37) is a kinase‐specific HSP90 cochaperone that stabilizes oncogenic kinases and is frequently overexpressed in malignancies, making it a compelling therapeutic target. Herein, we systematically delineate therapeutic strategies aimed at inhibiting CDC37, including modulating its Ser13 phosphorylation switch through CK2 inhibition or PP5 activation, disrupting the CDC37‐HSP90 complex, and blocking its interaction with kinase clients. These approaches culminate in the concerted degradation of multiple kinase client proteins. CDC37 inhibitors induce cell cycle arrest and apoptosis in models of colon cancer, prostate cancer, and others. Critically, by disrupting the thermal stability of kinases, CDC37‐targeting agents can resensitize resistant tumors to kinase inhibitors. In summary, targeting CDC37 is not only a novel anticancer strategy but also a paradigm‐shifting approach to address the persistent challenge of kinase inhibitor resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Cycle ProteinsAntineoplastic AgentsChaperoninsHumansApoptosisHSP90 Heat-Shock ProteinsProtein Kinase InhibitorsPhosphorylation

Stichwörter der Autor:innen

HSP90 cochaperonecell division cycle 37kinase inhibitor resistancekinase stabilization

Substanzen

Cell Cycle ProteinsAntineoplastic AgentsChaperoninsCDC37 protein, humanHSP90 Heat-Shock ProteinsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China.
  • Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.

ORCID-Profile: Qidong You, Lei Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province of China

Zitieren

APA

Zhang, L., Xin, Y., You, Q., & Wang, L. (2026). Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy. ChemMedChem. https://doi.org/10.1002/cmdc.202500794

Vancouver

Zhang L, Xin Y, You Q, Wang L. Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy. ChemMedChem. 2026. doi:10.1002/cmdc.202500794

BibTeX
@article{Zhang2026,
  author = {Zhang, Lixiao and Xin, Yuting and You, Qidong and Wang, Lei},
  title = {Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.202500794}
}
Kostenlos starten →